IL-36β and IL-36γ are known to promote epidermal hyperplasia, hyperkeratosis, and cutaneous inflammation in psoriasis, and IL-36γ is thought to be a key driver of psoriasis pathogenesis (14, 20), especially pustular psoriasis (21). Here, IL36G is linked to psoriasis.